Le rapport
Actualités vérifiées sur le financement, les sièges sociaux et les dirigeants des entreprises les plus innovantes au monde
23,723 rapports et plus encore
AngioDynamics Appoints Eric Honroth President and Chief Executive Officer
AngioDynamics announced that Eric Honroth, who most recently served as Global President, Life Science at Getinge, will become President and CEO on November 2, 2026, succeeding Jim Clemmer, who is retiring after ten years in the role.
Stryker Names Spencer Stiles Next Chief Executive Officer
Stryker named President and COO Spencer Stiles to succeed Kevin Lobo as CEO from January 1, 2027, with Lobo moving to Executive Chair of the Board and Stiles joining the Board.
Cadwell Names Jeff Cohen Chief Executive Officer
Cadwell named medical technology executive Jeff Cohen chief executive officer, succeeding Patrick Jensen, who concluded a 10-year tenure in the role and will remain with the company as a strategic advisor.
Providence Medical Technology Appoints Lane Major President and CEO
Providence Medical Technology’s board appointed former Zavation CEO Lane Major as President and CEO, and Major also joins the company’s board of directors.
TYBR Health Raises $30M Series A for Surgical Healing Products
TYBR Health raised a $30 million Series A led by Vensana Capital and Mutual Capital Partners to expand commercial access to its FDA-cleared B3 GEL System.
Nuwellis Appoints Mike McCormick Chief Executive Officer
Nuwellis appointed former board director Mike McCormick as CEO, effective June 30, 2026, as John Erb transitions from his executive role and continues as Chairman.
Baird Medical Establishes Global Headquarters in New York City
Baird Medical relocated its global headquarters to New York City to centralize leadership and support its US commercial expansion.
UniversalTranslator AI Secures $1.1B Series E for Cosmic-Scale Language Technology Technology
UniversalTranslator AI achieves $1.1B in Series E funding at $16.8B valuation to pioneer revolutionary language technology technology that could transform human civilization.
Masimo raises $150M Series D to accelerate growth and expansion
Masimo secures $150M in Series D funding to enhance its medical technology company specializing in noninvasive patient monitoring and expand market presence.
Affichage de 9 rapports • Page 1 • Catégorie : all
Restez en avance sur le marché
Recevez des insights hebdomadaires dans votre boîte de réception. Pas de spam, juste de l'intelligence.